Guardant Health, Inc. (GH) — 10-Q Filings
All 10-Q filings from Guardant Health, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Guardant Health Revenue Jumps 38% on Shield Test Momentum, Losses Narrow
— Oct 29, 2025 Risk: medium
Guardant Health, Inc. (GH) reported a significant increase in revenue for the three months ended September 30, 2025, reaching $265.2 million, up from $191.5 mil -
Guardant Health's Q2 Revenue Jumps 20%, But Losses Widen to $150M
— Jul 30, 2025 Risk: high
Guardant Health, Inc. reported a net loss of $150.0 million for the three months ended June 30, 2025, a significant increase from the $120.0 million net loss in - 10-Q Filing — Apr 30, 2025
-
Guardant Health Files Q3 2024 10-Q
— Nov 6, 2024 Risk: medium
Guardant Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024 and provides financial updates. Key d -
Guardant Health Files Q2 2024 10-Q
— Aug 7, 2024 Risk: medium
Guardant Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarte -
Guardant Health, Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
Guardant Health, Inc. (GH) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Guardant Health, Inc. filed a 10-Q report for the period ending March 31
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX